Lemborexant in Shift‑Work Insomnia

Lemborexant in Shift‑Work Insomnia

Type: Randomized controlled trial

Registration: NCT05344443

Status: Registered

Tags: Insomnia, Medication, Trial registration

External URL: https://clinicaltrials.gov/study/NCT05344443

Summary

Dual‑orexin receptor antagonist tested for insomnia complaints across night schedules.

Why It Matters For Night Shift Workers and Night Owls

An upcoming study is set to evaluate whether wake‑ or sleep‑promoting medication meaningfully shifts sleep, alertness, and metabolic markers for people who work nights. Quantified effects would show where medication sits alongside timing‑based approaches. The value for this audience is clarity: what’s measurable about the schedule, and where timing truly matters.

Tags

  • Insomnia
  • Medication
  • Trial registration

Notes

DORAs for sleep on nights.

← Back to Research